Reboxetine – 60 tb/4 mg – Pfizer – expires 06/2025 (shipped from Spain)


1 in stock


Reboxetine, sold under the brand name Edronax among others, is a drug of the norepinephrine reuptake inhibitor (NRI) class, marketed as an antidepressant by Pfizer for use in the treatment of major depression, although it has also been used off-label for panic disorder and attention deficit hyperactivity disorder (ADHD).